HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Dermatology
Meta-analysis
Mesenchymal Stem Cells Show Early Promise in Moderate-to-Severe Atopic Dermatitis
Stem cells show potential for treating severe atopic dermatitis
This meta-analysis pooled data from 236 patients with moderate-to-severe atopic dermatitis to evaluate mesenchymal stem cells. At week 12, 4…
Stem cells from umbilical cord blood and bone marrow may offer a new way to manage moderate to severe atopic dermatitis.
Oct 1, 2026
Oncology
Sys. Review
Functionalized mesenchymal stem cells and exosomes show potential for anti-inflammatory effects in allergic rhinitis
Stem Cells and Exosomes May Help Treat Allergic Rhinitis
This systematic review examines the efficacy of functionalized stem cells and their derivatives, such as exosomes, for managing allergic rhi…
New research explores how stem cells and their derivatives could offer a non-hormonal way to treat allergic rhinitis symptoms and inflammati…
Frontiers
Sep 30, 2026
Gastroenterology
Meta-analysis
Mesenchymal stem cells alleviate liver injury and inflammation in preclinical alcoholic hepatitis models
Stem cells show promise in treating liver damage from alcohol
This meta-analysis of transcriptomic signatures evaluates the effects of mesenchymal stem cells on alcoholic hepatitis in mice. The study fo…
New research in mice shows that stem cells may reduce liver inflammation and scarring caused by heavy alcohol use.
Sep 15, 2026
Rheumatology
Meta-analysis
MSC therapy improves salivary flow in Sjögren's animal models, meta-analysis finds
Stem cells show promise for Sjögren's syndrome in early research
This meta-analysis of 25 preclinical studies in animal models of Sjögren's syndrome found that mesenchymal stem cells (MSCs), MSC-derived ex…
Early research using stem cells and their components shows potential to improve saliva flow and reduce inflammation in Sjögren's syndrome mo…
Aug 3, 2026
Allergy & Immunology
Meta-analysis
Mesenchymal stem cell transplantation shows no significant improvement in EDSS scores for progressive multiple sclerosis
Stem cell therapy safe but no benefit for multiple sclerosis
This meta-analysis of 143 patients with progressive multiple sclerosis found that mesenchymal stem cell transplantation did not significantl…
A new analysis finds stem cell transplants are safe for progressive MS but don't improve disability scores.
Frontiers
Jul 22, 2026